SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
XOMA. Bull or Bear?
An SI Board Since July 1996
Posts SubjectMarks Bans Symbol
17367 72 0 XOMA
Emcee:  Olu Emuleomo Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
15992Delayed reaction or not, a very welcome movetom pope-8/16/2002
15991AH & H has a post call report out that does contain fresh insights, if not faknahow-8/16/2002
15990XOMA up over 15% on no fresh news Edit - and above average volumetom pope-8/16/2002
15989end of story...agree upon explanation... If the Sec look at xoma trading will fCacaito-8/15/2002
15988Hey Cacaito, I'm just an idiot still asking the question.......WHY isn'tBluegreen-8/15/2002
15987Cacaito, do you remember what sent Xoma down sharply? April 5, 2002 -- Genentecaknahow-8/15/2002
15986It does not sound like any "ratio", it talks about NEGATIVE results! TCacaito-8/15/2002
15985The delay in filing the BLA due to the failure of Genentech to meet the agreed aknahow-8/15/2002
15984Which NEGATIVE results cause a 42% drop in April??? ..."allegedly found neCacaito-8/15/2002
15983Thursday August 15, 4:26 pm Eastern Time Dow Jones Business News Ex-Biotech Empaknahow-8/15/2002
15982Biosite license "its" phage technology to MEDI, is like the xoma lawsuCacaito-8/15/2002
15981Bax already spent lots of $ in the Fda rejected meningo indication of Neuprex. Cacaito-8/15/2002
15980Cacaito, I DON'T GET IT!!!! Why would Baxter go through the process of gettBluegreen-8/15/2002
15979Thanks, Cacaito, your explanation seems logical to me. "..the subjects areaknahow-8/15/2002
15978I do not think they need permission, they are providers to research, they are coCacaito-8/15/2002
15977Cacaito, does this place need permission from Xoma??? athensresearch.comBluegreen-8/15/2002
15976Cacaito, what are your thoughts on why Baxter is taking so long to advance NeuprBluegreen-8/14/2002
15975Gw, cause there is room for many therapies, many combos, they, and especially BiCacaito-8/14/2002
15974"Alefacept has been tested in phase I, II, and III clinical trials. In a phaknahow-8/14/2002
15973okay George and Cacaito, who's ahead? medscape.com|4328847870651871130/1841tom pope-8/14/2002
15972Funny that everyone believes corporate espionage exist but most investors in bioaknahow-8/14/2002
15971Besides spionage fiction also trader fiction !!!Cacaito-8/14/2002
15970finance.yahoo.com^BPI&d=c&k=c1&c=xoma&a=v&p=s&t=3m&laknahow-8/14/2002
15969Larry, if a company has thousands of employees I would expect that any infiltrataknahow-8/14/2002
15968If the fake patient was ever discovered, or if he talked about it later to the mLarryS-8/14/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News